NASDAQ:MRNA - Nasdaq - US60770K1079 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 3.24B | 6.85B | 19.26B | 18.47B | 803.00M | |||
Cost Of Goods | 1.46B | 2.49B | 5.42B | 2.62B | 8.00M | |||
Gross Profit | 1.77B | 4.36B | 13.85B | 15.85B | 795.00M | |||
Operating Expenses | 5.72B | 6.39B | 4.43B | 2.56B | 1.56B | |||
Research and Development | 4.54B | 4.84B | 3.29B | 1.99B | 1.37B | |||
Selling, General, and Administrative Expenses | 1.17B | 1.55B | 1.13B | 567.00M | 188.00M | |||
Operating Income | -3.94B | -2.04B | 9.42B | 13.30B | -763.00M | |||
Interest Income/Expense | 425.00M | 311.00M | 151.00M | 1.00M | 16.00M | |||
Other Income/Expense | -87.00M | -14.00M | 4.00M | -12.00M | 3.00M | |||
Non Recurring Items | N/A | -2.20B | N/A | N/A | N/A | |||
Income Before Taxes | -3.61B | -3.94B | 9.57B | 13.29B | -745.00M | |||
Income Tax | -46.00M | 772.00M | 1.21B | 1.08B | 3.00M | |||
Net Income | -3.56B | -4.71B | 8.36B | 12.20B | -747.00M | |||
EBITDA | -3.76B | -1.42B | 9.77B | 13.53B | -732.00M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -9.27 | -12.34 | 20.10 | 28.31 | -1.96 | |||
Non GAAP EPS | -8.87 | -12.41 | 19.96 | 28.29 | -1.94 | |||
Statistics | ||||||||
Gross Profit Margin | 54.76% | 63.60% | 71.88% | 85.83% | 99.00% | |||
Profit Margin | -110.04% | -68.84% | 43.41% | 66.06% | -93.03% | |||
Operating Profit Margin | -121.91% | -29.78% | 48.90% | 71.98% | -95.02% |
All data in USD